Notizie e Video - BIOLIFE SOLUTIONS INC.

BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences PR Newswire BOTHELL, Wash., March 4, 2024 BOTHELL, Wash. , March 4, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced that Roderick de Greef , Chief Executive Officer, and Troy Wichterman, Chief Financial Officer, will present and meet with current and...

BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire BOTHELL, Wash., Feb. 29, 2024 Fourth quarter Cell Processing revenue up 11% sequentially to $14.8 million , and positive adjusted EBITDA of $700,000 Expects 2024 revenue of $95.5 - $100.0 million excluding freezer business and positive adjusted EBITDA Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash. , Feb. 29, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the...

BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024 PR Newswire BOTHELL, Wash., Feb. 20, 2024 BOTHELL, Wash. , Feb. 20, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's fourth quarter and full year 2023 financial results will be released after...

BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue PR Newswire BOTHELL, Wash., Jan. 8, 2024 Fourth quarter Cell Processing revenue increased 11% sequentially to $14.8 million BOTHELL, Wash. , Jan. 8, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced 2023...

BioLife Solutions Reports Third Quarter 2023 Financial Results PR Newswire BOTHELL, Wash., Nov. 9, 2023 Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash. , Nov. 9, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the third quarter and...

BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023 PR Newswire BOTHELL, Wash., Nov. 2, 2023 BOTHELL, Wash. , Nov. 2, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter financial results will be released after market close on Thursday, November 9,...

BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023 PR Newswire BOTHELL, Wash., Oct. 19, 2023 Roderick de Greef appointed Chairman and Chief Executive Officer bringing 20+ years of prior BioLife experience Garrie Richardson appointed Chief Revenue Officer Preliminary Q3 revenue of $33.3 million and expect 2023 revenue at the low end of the previously announced guidance range BOTHELL, Wash. , Oct. 19, 2023 /PRNewswire/ -- BioLife...

BioLife Solutions Reports Second Quarter 2023 Financial Results, Updates Full Year 2023 Guidance and Provides Pro Forma First Half 2023 Financial Profile Excluding Freezer Business PR Newswire BOTHELL, Wash., Aug. 8, 2023 Committed to Divesting Stirling Ultracold and Custom Biogenic Systems by End of 2023 Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash. , Aug. 8, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of...

BioLife Solutions to Provide Second Quarter 2023 Financial Results and Business Update on August 8, 2023 PR Newswire BOTHELL, Wash., July 27, 2023 BOTHELL, Wash. , July 27, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's second quarter financial results will be released after market close on Tuesday, August 8,...

BioLife Solutions Receives College of American Pathologists CAP-BAP Accreditation for All SciSafe® U.S. Biostorage Facilities PR Newswire BOTHELL, Wash., June 14, 2023 BOTHELL, Wash. , June 14, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced that all of its SciSafe-branded biostorage facilities in the USA have been accredited...

BioLife Solutions Launches the IntelliRate™ i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer PR Newswire BOTHELL, Wash., June 6, 2023 Large-Capacity Tabletop Freezer Expands Line of Controlled-Rate Freezers for Cell and Gene Therapies; Now Available for Order BOTHELL, Wash. , June 6, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy...

BioLife Solutions Reports First Quarter 2023 Financial Results PR Newswire BOTHELL, Wash., May 10, 2023 Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28% Q1 2023 Adjusted gross margin improvement; 37% compared to 32% in Q4 2022 Decision to Explore Strategic Alternatives for Ultra-Low Temperature and Cryogenic Freezer Product Lines Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash. , May 10, 2023...

BioLife Solutions to Provide First Quarter 2023 Financial Results and Business Update on May 10, 2023 PR Newswire BOTHELL, Wash., May 2, 2023 BOTHELL, Wash. , May 2, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's first quarter financial results will be released after market close on Wednesday, May 10, 2023 . The...

BioLife Solutions Reports Preliminary and Unaudited 2022 Fourth Quarter and Full Year Financial Results PR Newswire BOTHELL, Wash., March 16, 2023 Record full year revenue of $161.8 million increased 36% over 2021; biopreservation media revenue growth of 45%, validating leading position as a critical cell and gene therapies (CGT) tools and services supplier Record Q4 2022 revenue of $44.3 million increased 19% over 2021; biopreservation media revenue growth of 35% Full year adjusted EBITDA of...

BioLife Solutions Reports Immaterial Financial Exposure to Silicon Valley Bank PR Newswire BOTHELL, Wash., March 10, 2023 BOTHELL, Wash. , March 10, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today provided commentary on its current banking relationship with Silicon Valley Bank ("SVB"). BioLife is monitoring the situation at SVB...

BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023 PR Newswire BOTHELL, Wash., March 9, 2023 BOTHELL, Wash. , March 9, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's fourth quarter and full year 2022 financial results will be released...

BioLife Solutions Launches Ultraguard™ -70°C Phase Change Material (PCM) Accessory to Provide Backup Cooling in ULT Freezers and Dry Ice Alternative for Benchtop Biologic Material Storage PR Newswire BOTHELL, Wash., March 1, 2023 Exclusive global supplier of non-toxic, non-flammable PCM; first to operate at -70 ° C, meeting critical temperature requirement of biologic materials. BOTHELL, Wash. , March 1, 2023 /PRNewswire/ -- BioLife Solutions, Inc . (NASDAQ: BLFS), a leading supplier of...

BioLife Solutions Announces 2023 Analyst Day & Participation in Upcoming Investor Conferences PR Newswire BOTHELL, Wash., Jan. 17, 2023 BOTHELL, Wash. , Jan. 17, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced the dates of its 2023 analyst day and upcoming investor conferences where...

BioLife Solutions Named One of Seattle Business Magazine's Washington's Best Companies to Work For PR Newswire BOTHELL, Wash., Jan. 10, 2023 Fourth Time Company Recognized in the Last Nine Years BOTHELL, Wash. , Jan. 10, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced that the...

BioLife Solutions Announces 2022 Fourth Quarter and Full Year Preliminary Unaudited Revenue and Introduces 2023 Revenue Guidance PR Newswire BOTHELL, Wash., Jan. 9, 2023 Record quarterly revenue of $44.4 million up 19% over Q4 2021 with Cell Processing Platform revenue growth of 37% Record full year revenue of $161.9 million up 36% over 2021, with organic revenue growth of 38% and Cell Processing Platform revenue growth of 53% Initial revenue guidance for 2023 of $188 million to $202 million ,...